CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...
Phase 2
Salt Lake City, Utah, United States and 23 other locations
escalation will be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer...
Phase 1
Salt Lake City, Utah, United States and 1 other location
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Salt Lake City, Utah, United States and 223 other locations
to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors...
Phase 1
West Valley City, Utah, United States of America and 20 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Salt Lake City, Utah, United States and 505 other locations
and tolerability of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast cancer and solid tumors...
Phase 1
West Valley City, Utah, United States and 3 other locations
This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors....
Phase 1, Phase 2
Salt Lake City, Utah, United States and 4 other locations
activity of GEN1107 (PRO1107) in participants with advanced solid tumors. This study consists of 2 parts, Part A: dose escalation and dose l...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 5 other locations
This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It wi ...
Phase 1
West Valley City, Utah, United States of America and 43 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 36 other locations
Clinical trials
Research sites
Resources
Legal